Optimind Pharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '25 Aug 19, 2025	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022
Market Capitalization	1	1	0	4	-
Market Cap Growth	-	11.92%	-87.47%	-	-
Enterprise Value	1	1	1	4	-
Last Close Price	0.01	0.01	0.01	0.04	-
PS Ratio	3.92	4.64	3.99	23.01	-
PB Ratio	-4.74	-7.34	-3.80	6.12	-
P/TBV Ratio	-	-	-	14.58	-
EV/Sales Ratio	4.03	4.83	8.37	21.79	-
Debt / Equity Ratio	-1.11	-1.68	-0.97	0.96	0.04
Net Debt / Equity Ratio	-0.25	-0.56	-0.75	0.10	-0.40
Net Debt / EBITDA Ratio	-	-	-0.13	-0.07	3.09
Asset Turnover	0.65	0.54	0.15	0.07	-
Quick Ratio	0.47	0.55	0.51	1.07	2.04
Current Ratio	0.47	0.55	0.51	1.07	2.80
Return on Equity (ROE)	-	-	-547.28%	-167.32%	-
Return on Assets (ROA)	-14.29%	-57.51%	-59.12%	-21.94%	-
Return on Capital Employed (ROCE)	42.50%	269.50%	583.80%	-124.30%	-12.80%
Earnings Yield	-12.89%	-39.31%	-284.95%	-78.65%	-
Buyback Yield / Dilution	4.35%	-12.00%	-21.38%	-88.09%	-

Source: S&P Capital IQ. Standard template. Financial Sources.